No golden signals this cycle (RSI<30 + insider buying) — zero for a third straight scan. The clearest new technical damage is ISRG, which has gone from a mild pullback (RSI 45.0 last scan) to RSI 30.2 this cycle — a quality surgical-robotics name now sitting at the edge of the oversold threshold with its thesis still flagged intact. NFLX and NTLA both deepened further, continuing multi-scan deterioration with no stabilization signal. Insider buying stays at the same three names as last scan — TSLA, CRSP, ASAN — and the underlying dollar figures for most names (buying and selling alike) carry over essentially unchanged from the 07-11 report, suggesting little fresh Form-4 activity this week; ABNB, NET, and DDOG are the exceptions, showing modestly larger net selling.

Data as-of 2026-07-17 close. Source: the desk's own tooling (live insider Form-4 net dollars) cross-referenced against summaries/insider-universe.json for price/RSI/structure — CLI prices matched the summary exactly on every name checked. Note: the CLI's own RSI calculation differs from the summary's precomputed RSI on several names (a known basis difference between tools); this report uses the summary RSI throughout for consistency and cites the CLI only for insider dollar flows. Prior scan: 2026-07-11-insider-scan.

Insider buying is unchanged from last scan: TSLA (+$205.3M net), CRSP (+$28.1M), and ASAN (+$8.4M) are still the only three names with net accumulation, and the dollar figures are identical to the 07-11 report — no new buying activity is visible in this window. None of the three sits inside clean technical structure: TSLA cooled further (RSI 51.5→42.5, price down from $407.76 to $380.84, still death-crossed pullback); CRSP deteriorated meaningfully — the "cooling out of overbought with insider buying" story from last scan has since turned into a real decline (RSI 45.8→36.2, 30D flipped from +6.2% to -11.67%), with no golden-cross confirmation materializing; ASAN improved modestly (RSI 53.5→58.1, 30D +11.13%).

Selling remains broad and mostly unchanged in dollar terms from last scan — AMZN (-$9.2B), NVDA (-$3.3B), LLY (-$3.1B), and PLTR (-$2.5B) all carry the exact same net figures as 07-11, suggesting the underlying filings window hasn't turned over materially. The few names that did move: ABNB (-$886.6M, was -$850.4M), NET (-$771.8M, was -$744.5M), and DDOG (-$698.8M, was -$668.3M) all grew modestly, while SNOW's figure shrank to -$1.2B (was -$1.5B). Structure-wise, PLTR actually improved slightly this cycle (RSI 48.4→52.9, 30D -3.3%→+3.04%) even as its selling flag persisted unchanged, while NFLX continued deepening (RSI 37.5→30.5, right at the edge of oversold, 30D -9.7%→-10.89%) — now three scans running with no stabilization. DOCN remains the scan's clearest "selling into an intact uptrend" case, though its cushion above the 200-day compressed sharply (+60.9%→+42.9% vs SMA200) even as the golden cross stays intact and the -$673.7M selling figure carries over unchanged.

ISRG is the cycle's most notable new technical flag. Last scan it sat at RSI 45.0 in the bargain-bin's "approaching oversold" tier; this cycle it's cratered to RSI 30.2 (7D -15.08%, 30D -15.08%, price down from $406.78 to $345.42), now in collapse regime and -42.8% off its 52-week high — a real, fresh deterioration in a name whose thesis is still tagged intact, not a bounce candidate. It carries no insider-buying flag from the CLI, so per desk doctrine this stays a technical extreme to watch, not a signal. The prior scan's biotech cooldown (MRNA/VRTX/NTLA/CRSP) has continued into a second leg down for two of the four: NTLA deepened from RSI 42.2 to RSI 30.5 (its vs-SMA200 cushion flipped from +3.6% to -16.4%), and CRSP fell as described above — while MRNA and VRTX (not shown in this scan's oversold tier) held closer to their prior levels. EOSE remains the single most oversold name in the tracked universe at RSI 30.1, collapse regime, -60.1% vs SMA200 — still no insider-buying confirmation.

This is a price-and-structure screen cross-referenced with live insider Form-4 net dollars — not a recommendation engine. "Insider buying" flags net accumulation; it says nothing about whether the chart is worth owning. A low RSI paired with insider buying is only a genuine "golden" signal below RSI 30 — everything else is a data point to weigh, not a trigger. This cycle's insider dollar totals carried over largely unchanged from the last scan on most names — read that as "little new filing activity," not as continued conviction one way or the other; ABNB/NET/DDOG/SNOW are the names where the figure actually moved. Structure labels — intact (golden cross, uptrend/basing), damaged (death cross, downtrend/collapse), extended (large positive vs SMA200 in an uptrend) — describe the chart only.

(DOCN's -$673.7M net selling sits inside this magnitude range too, but the CLI buckets it under "selling into dip" below due to its low RSI — see that table rather than double-counting it here. 26 more names carry net insider selling below this cut, including NTLA, UI, CEG, BNTX, INTC, TSM, ENPH, MRNA, AKAM — none flagged "selling into dip" beyond the table below.)

(23 remaining tracked names — MRVL, QCOM, GOOGL, CRM, MSFT, ARM, ZS, ASML, MDB, UBER, NOW, FSLY, HIMS, IBKR, CRWD, SHOP, FTNT, PINS, AFRM, U, TMO, META, MRNA — sit at RSI 42-63, basing/steady, no fresh insider-buy or heavy-selling flag surfaced by the CLI's top cuts this cycle.)

Buying, unchanged and not clean — TSLA/CRSP/ASAN are still the only net-buying names, with dollar figures identical to last scan. CRSP is now the most concerning of the three: the "cooling out of overbought with buying" story from 07-11 has turned into a real -11.7% 30-day decline instead of a base.

New technical cracks — ISRG (RSI 45.0→30.2) and NTLA (RSI 42.2→30.5) both fell into genuine oversold territory this cycle, joining NFLX (now three scans deep in the same state) and the already-oversold EOSE. None carry insider-buying confirmation.

Heavy selling, intact structure — AMZN, NVDA, LLY, AVGO, PANW, SNOW, ABNB, NET, DDOG, DOCN, TWLO, BE, AAPL, AMD all show large insider selling dollars but sit inside intact (golden cross) technical structure — read as scale-driven, not a bearish tell on its own.

Heavy selling, damaged structure — verification-worthy — PLTR (-$2.5B, structure improving slightly) and NFLX (-$1.4B, deteriorating) both pair large insider selling with death-cross/downtrend-or-collapse charts. Worth outside verification before any accumulate call on either.

Frozen dollar totals — the majority of both buying and selling figures carried over unchanged from 07-11, suggesting a quiet filing window; ABNB/NET/DDOG grew modestly and SNOW shrank, the only names where the number itself moved.

• Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-07-17 close — *.